Covered recipient · General Payments record
MOHAMMAD KHALIL
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,006.82
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.52 | 14 |
| Education | $16.72 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Tempus AI, Inc | $80.70 | 3 |
| EISAI INC. | $54.22 | 2 |
| SOBI, INC | $32.52 | 1 |
| ABBVIE INC. | $24.43 | 1 |
| Grifols USA, LLC | $20.89 | 1 |
| Pharming Healthcare, Inc. | $18.17 | 1 |
| BeiGene USA, Inc. | $17.86 | 1 |
| Janssen Biotech, Inc. | $16.92 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
| PFIZER INC. | $15.70 | 1 |
| Fennec Pharmaceuticals, Inc. | $14.83 | 1 |
| Merck Sharp & Dohme Corporation | $14.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.43 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104058406 | CMS |
| BeiGene USA, Inc. | $17.86 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120865032 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 10/08/2024 | Education | Undisputed | 01/23/2026 | 1144444476 | CMS |
| Eisai Inc. | $22.21 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110767661 | CMS |
| Eisai Inc. | $32.01 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110767663 | CMS |
| Fennec Pharmaceuticals, Inc. | $14.83 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120186450 | CMS |
| Grifols USA, LLC | $20.89 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124719550 | CMS |
| Janssen Biotech, Inc. | $16.92 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078779806 | CMS |
| Merck Sharp & Dohme LLC | $14.28 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141930385 | CMS |
| PFIZER INC. | $15.70 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131296688 | CMS |
| Pharming Healthcare, Inc. | $18.17 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132152850 | CMS |
| SOBI, INC | $32.52 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141416286 | CMS |
| Tempus AI, Inc | $28.60 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150167562 | CMS |
| Tempus AI, Inc | $22.22 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150167564 | CMS |
| Tempus AI, Inc | $29.88 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150167566 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.